ID

31881

Beschreibung

Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"; ODM derived from: https://clinicaltrials.gov/show/NCT01030861 Collaborating Parties: National Institute of Allergy and Infectious Diseases (NIAID) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Center for Research Resources (NCRR) Juvenile Diabetes Research Foundation American Diabetes Association

Link

https://clinicaltrials.gov/show/NCT01030861

Stichworte

  1. 07.10.18 07.10.18 -
Rechteinhaber

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Hochgeladen am

7. Oktober 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Type 1 Prevention NCT01030861

Eligibility Diabetes Type 1 Prevention NCT01030861

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
between ages of 8-45 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
have a relative with type 1 diabetes
Beschreibung

- if first degree relative must be 8-45 years old (brother, sister, parent, offspring) - if second degree relative must be between 8-20 years old (niece, nephew, aunt, uncle, grandchild, cousin)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0080103
UMLS CUI [1,2]
C0011854
UMLS CUI [2,1]
C0001779
UMLS CUI [2,2]
C0080103
abnormal glucose tolerance by ogtt confirmed with 7 weeks of baseline visit [fasting blood glucose greater than 110mg/dl or and less than 126 mg/dl or 2 hour glucose greater or equal to 140 mg/dl and less than 200 mg/dl or 30, 60, or 90 minute value on ogtt greater than or equal to 200 mg/dl]
Beschreibung

Abnormal glucose tolerance confirmed by ogtt, with fasting blood glucose or 2 hour glucose

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0235401
UMLS CUI [1,2]
C0029161
UMLS CUI [2,1]
C0235401
UMLS CUI [2,2]
C0428568
UMLS CUI [3,1]
C0235401
UMLS CUI [3,2]
C2238058
presence of at least two confirmed diabetes autoantibodies
Beschreibung

Presence of diabetes autoantibodies

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004358
UMLS CUI [1,2]
C0011854
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes previously diagnosed or detected at screening [fasting glucose greater or equal to 126 mg/dl or 2 hour glucose greater or equal to 200 mg/dl]
Beschreibung

Current type 1 diabetes (fasting glucose, 2 hour glucose)

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0262926
UMLS CUI [2]
C0583513
UMLS CUI [3]
C2238058
abnormalities in blood counts, liver enzymes, inr, positive ppd Test
Beschreibung

Abnormalities in blood counts, liver enzymes, inr or positive ppd test

Datentyp

boolean

Alias
UMLS CUI [1]
C0525032
UMLS CUI [2]
C0041290
UMLS CUI [3]
C0009555
UMLS CUI [4]
C1287351
vaccination with live virus within 6 weeks of randomization
Beschreibung

Recent vaccination with live virus

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1516086
UMLS CUI [1,2]
C0332185
evidence of acute infection based on laboratory testing or clinical evidence
Beschreibung

Acute infection

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0022885
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0205210
serological evidence of past current or past hiv , hepatitis b, or hepatitis c infection
Beschreibung

Past HIV, Hepatitis B or Hepatitis C infection

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019693
UMLS CUI [1,2]
C0036743
UMLS CUI [2,1]
C0019163
UMLS CUI [2,2]
C0036743
UMLS CUI [3,1]
C0019196
UMLS CUI [3,2]
C0036743
be currently pregnant or lactating
Beschreibung

Pregnant or lactating

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
prior treatment with study drug
Beschreibung

Prior treatment with study drug

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1521826
prior treatment with other monoclonal antibody in past one year
Beschreibung

Prior treatment with monoclonal antibody

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0003250

Ähnliche Modelle

Eligibility Diabetes Type 1 Prevention NCT01030861

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
between ages of 8-45 years
boolean
C0001779 (UMLS CUI [1])
Relatives with Type 1 diabetes between 8-45 years old
Item
have a relative with type 1 diabetes
boolean
C0080103 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2,1])
C0080103 (UMLS CUI [2,2])
Abnormal glucose tolerance confirmed by ogtt, with fasting blood glucose or 2 hour glucose
Item
abnormal glucose tolerance by ogtt confirmed with 7 weeks of baseline visit [fasting blood glucose greater than 110mg/dl or and less than 126 mg/dl or 2 hour glucose greater or equal to 140 mg/dl and less than 200 mg/dl or 30, 60, or 90 minute value on ogtt greater than or equal to 200 mg/dl]
boolean
C0235401 (UMLS CUI [1,1])
C0029161 (UMLS CUI [1,2])
C0235401 (UMLS CUI [2,1])
C0428568 (UMLS CUI [2,2])
C0235401 (UMLS CUI [3,1])
C2238058 (UMLS CUI [3,2])
Presence of diabetes autoantibodies
Item
presence of at least two confirmed diabetes autoantibodies
boolean
C0004358 (UMLS CUI [1,1])
C0011854 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Current type 1 diabetes (fasting glucose, 2 hour glucose)
Item
type 1 diabetes previously diagnosed or detected at screening [fasting glucose greater or equal to 126 mg/dl or 2 hour glucose greater or equal to 200 mg/dl]
boolean
C0011854 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0583513 (UMLS CUI [2])
C2238058 (UMLS CUI [3])
Abnormalities in blood counts, liver enzymes, inr or positive ppd test
Item
abnormalities in blood counts, liver enzymes, inr, positive ppd Test
boolean
C0525032 (UMLS CUI [1])
C0041290 (UMLS CUI [2])
C0009555 (UMLS CUI [3])
C1287351 (UMLS CUI [4])
Recent vaccination with live virus
Item
vaccination with live virus within 6 weeks of randomization
boolean
C1516086 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Acute infection
Item
evidence of acute infection based on laboratory testing or clinical evidence
boolean
C0009450 (UMLS CUI [1,1])
C0022885 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C0205210 (UMLS CUI [2,2])
Past HIV, Hepatitis B or Hepatitis C infection
Item
serological evidence of past current or past hiv , hepatitis b, or hepatitis c infection
boolean
C0019693 (UMLS CUI [1,1])
C0036743 (UMLS CUI [1,2])
C0019163 (UMLS CUI [2,1])
C0036743 (UMLS CUI [2,2])
C0019196 (UMLS CUI [3,1])
C0036743 (UMLS CUI [3,2])
Pregnant or lactating
Item
be currently pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Prior treatment with study drug
Item
prior treatment with study drug
boolean
C1514463 (UMLS CUI [1,1])
C1521826 (UMLS CUI [1,2])
Prior treatment with monoclonal antibody
Item
prior treatment with other monoclonal antibody in past one year
boolean
C1514463 (UMLS CUI [1,1])
C0003250 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video